D.E. Shaw & Co
AONC

D.E. Shaw & Co’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

D.E. Shaw & Co’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,430,179
Closed -$14.4M – 4993
2022
Q4 		$14.4M Buy
1,430,179
+757,536
+113% +$7.52M 0.02% 1138
2022
Q3 		$6.61M Hold
672,643
– – 0.01% 1772
2022
Q2 		$6.58M Sell
672,643
-842,126
-56% -$8.24M 0.01% 1800
2022
Q1 		$14.8M Buy
1,514,769
+157,969
+12% +$1.53M 0.01% 1262
2021
Q4 		$13.1M Buy
1,356,800
+473,300
+54% +$4.61M 0.01% 1422
2021
Q3 		$8.57M Buy
883,500
+634,843
+255% +$6.16M 0.01% 1634
2021
Q2 		$2.41M Buy
+248,657
New +$2.43M ﹤0.01% 2757

Other funds holding AONC

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

D.E. Shaw & Co's AONC Position: Q1 2023 in Review

D.E. Shaw & Co sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 1,430,179 shares — an estimated $14.4M sold.

D.E. Shaw & Co first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $14.8M in Q1 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • D.E. Shaw & Co reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,430,179 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $14.4M.
  • D.E. Shaw & Co first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's American Oncology Network, Inc. Class A Common Stock position peaked at $14.8M in Q1 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.